Search

Your search keyword '"Yanggang, Yuan"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Yanggang, Yuan" Remove constraint Author: "Yanggang, Yuan" Search Limiters Full Text Remove constraint Search Limiters: Full Text
89 results on '"Yanggang, Yuan"'

Search Results

1. Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome

2. Animal models of membranous nephropathy: more choices and higher similarity

3. Quantification of urinary podocyte‐derived migrasomes for the diagnosis of kidney disease

4. High sodium intake and fluid overhydration predict cardiac structural and functional impairments in chronic kidney disease

5. The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy

6. Therapeutic effects and mechanism of human amnion-derived mesenchymal stem cells on hypercoagulability in a uremic calciphylaxis patient

7. Clinicopathological characteristics and outcome predictors of anti-glomerular basement membrane glomerulonephritis

8. Serum 25-hydroxyvitamin D as a predictive biomarker of clinical outcomes in patients with primary membranous nephropathy

9. Mitochondrial dynamics in vascular remodeling and target-organ damage

10. Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder

11. Characteristics of urinary sodium excretion in patients with chronic kidney disease in Jiangsu, China

12. SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation

13. Association of Serum 25 (OH) Vitamin D With Chronic Kidney Disease Progression in Type 2 Diabetes

14. Value of monitoring urine ammonia at time of biopsy in patients with lupus nephritis

15. Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy

16. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction

17. Impact of Overhydration on Left Ventricular Hypertrophy in Patients With Chronic Kidney Disease

18. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism

20. Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease

21. Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease

22. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

23. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes

24. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression

25. Mitochondrial Fission Is Required for Angiotensin II-Induced Cardiomyocyte Apoptosis Mediated by a Sirt1-p53 Signaling Pathway

26. P53 Contributes to Cisplatin Induced Renal Oxidative Damage via Regulating P66shc and MnSOD

27. Delta corticomedullary apparent diffusion coefficient on MRI as a biomarker for prognosis in IgA nephropathy

28. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease

29. Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy

30. MO133: Multidisciplinary Regenerative Treatment for Rescuing a Severe Calciphylaxis Patient with Human Amnion-Derived Mesenchymal Stem Cells

31. A novel long-term intravenous combined with local treatment with human amnion-derived mesenchymal stem cells for a multidisciplinary rescued uremic calciphylaxis patient and the underlying mechanism

32. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction

33. Pre-clinical Research of Human Amnion-derived Mesenchymal Stem Cells and its First Clinical Treatment for a Severe Uremic Calciphylaxis Patient

34. Commentary: Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

35. Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease

36. SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation

37. Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy

38. Protective effect of the BET protein inhibitor JQ1 in cisplatin-induced nephrotoxicity

39. Hyperoside alleviates adriamycin-induced podocyte injury via inhibiting mitochondrial fission

40. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression

41. Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease

42. Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity

43. Targeting HSP90 attenuates angiotensin II-induced adventitial remodelling via suppression of mitochondrial fission

44. Drp1-dependent mitophagy protects against cisplatin-induced apoptosis of renal tubular epithelial cells by improving mitochondrial function

45. Reactive oxygen species-initiated autophagy opposes aldosterone-induced podocyte injury

46. PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria

48. The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone/mineralocorticoid receptor-induced podocyte injury

49. p53/Drp1-dependent mitochondrial fission mediates aldosterone-induced podocyte injury and mitochondrial dysfunction

50. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy

Catalog

Books, media, physical & digital resources